NextCure, Inc.
Pharmaceutical Preparations · Baltimore, MD, United States
- PrincipalsMichael RichmanPresident & CEOSteven P. CobournChief Financial OfficerTimothy MayerChief Operating Officerand 3 more
- CompanyNextCure, Inc.Baltimore, MD, United States
- Phone line+1 (240) 399-4900General business
NextCure, Inc. is an SEC-registered Nasdaq-listed company (ticker NXTC) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 6
Chief executive
Michael RichmanPresident & CEO
Finance
Steven P. CobournChief Financial Officer
Operations
Timothy MayerChief Operating Officer
Legal
Kevin G. ShawSr VP, General Counsel
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Michael Richman — President & CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Steven P. Cobourn — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Timothy Mayer — Chief Operating Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Udayan Guha — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Incannex Healthcare Inc.Pharmaceutical Preparations · Norwest Nsw1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capability